Skip to content

Public FDA record

Z-0981-2024: Access Ultrasensitive Insulin only used on the DxI 9000 Access Immunoassay Analyzer, Catalog Number 33410

Recall record Z-0981-2024 for Beckman Coulter, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0981-2024
Company in FDA record
Beckman Coulter, Inc.
FDA classification date
Feb 5, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There is an issue with the Access Ultrasensitive Insulin assay protocol file (APF) for use with the DxI 9000 Access Immunoassay Analyzer (APF 182 test definition version 6.7 and below). The Access Ultrasensitive Insulin APF applies an incorrect conversion factor when converting from system default units of IU/mL to the International System of Units (SI units) of pmol/L.

Source facts

Action
Beckman Coulter issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 12/21/2023 via US mail and email. The notices explained the issues with the devices, the impact on test results, and requested the following actions be taken: Issue 1 - Configure the Access Ultrasensitive Insulin assay to the system default units (IU/mL). Refer to the appropriate system manuals for instructions. To manually convert concentrations to SI units (pmol/L), multiply IU/mL by a multiplication factor of 7.0. Issue 2 - If the DxI 9000 Access Immunoassay Analyzer is connected to a host system, you can configure the host system to convert results from the system default units to the desired reporting units. If the DxI 9000 analyzer is not connected to a host system, revert all Access assays to their system default units to be sure the analyzer accurately reports dilution assay test results. Perform a retrospective review of all dilution assay test results that were reported in units other than the system default units. Issue 3 - Discontinue using the calculated result feature on the DxI 9000 user interface. Calculations can be performed manually or at the host system. For assay results that have already been run, if a calculated result of 0 was obtained, perform a retrospective review to ensure none of the assay results contained a > or < result. If any of the assay results contained a > or < then the calculated result interpretation should be corrected to no result . Issue 4 - If a reserve volume order is not run automatically as identified by a sample event notification, reload the sample to complete the ordered test. Alternatively, to ensure reserve volume is aliquoted, on the Menu > System Configuration > Test Menu screen, reenter the assay LIS code to match the assay Test ID shown on screen. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have
Initiated
2023-11-21
Root cause
Software design
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Croatia, Czech Republic, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom.
Recall number
Z-0981-2024
Recall status
Open, Classified
CDRH record ID
205314
FDA classified
2024-02-05
Recall event number
93724

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗